Tirilazad

DB13050InvestigationalSmall molecule

Tirilazad has been used in trials studying the treatment of Spinal Cord Injury.

Chemical structure of Tirilazad
Formula / weight
C38H52N6O2 · 624.874 g/mol (avg)
Code names
U-74006

Resolves to

Compound
UNIIYD064E883ICAS110101-66-1ChEMBLCHEMBL1630578ChEBI135853PubChem104903
Clinical / RWD
RxNorm72467ATCN07XX01
Structure
InChIKeyRBKASMJPSJDQKY-RBFSKHHSSA-NSMILESC[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(CC1)C1=CC(=NC(=N1)N1CCCC1)N1CCCC1

What you can answer from here — as of August 07, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Tirilazad, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In